HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

902.195

-20.647-2.24%

Number of Gainers:5

Number of Losers:6

Number of Flat:2

PE:- -

High:922.651

Open:922.651

Low:893.993

Close:922.842

Volume:134.00M

Turnover:937.12M

Market Cap:148.50B

Float Cap:111.37B

Loading ...

Press Release: Angel's Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule

Angelalign Technology Logs HY Revenue of USD 230.70 Million

Angelalign Technology (SEHK:6699) Is Getting Fresh Attention, What Is The Market Weighing?

Simply Wall St.

Angelalign's Global Expansion Accelerates in First Half of 2026, with Steady Gains in Mainland China Market Share

China's Hongcheng Environmental Technology HY Revenue Rises on Higher Sulphuric Acid Prices

RAILY AESMED Cancels 47.28 Million Unexercised Share Options

Angelalign Technology Declares Interim Dividend of HKD 0.47 Per Share

Raily Aesthetic Medicine Cancels 47,276,437 Share Options Outstanding Under Incentive Scheme

China's Angelalign H1 Revenue Rises on Higher Clear Aligner Case Volume

Angelalign FY26 H1 Net Profit Climbs 79.6% to USD 25.5 Million; Revenue Rises 42.9% to USD 230.7 Million

Angelalign Technology - Declares Interim Dividend HKD 0.47 Per Share and Special Dividend HKD 4.10 Per Share

THOMSON REUTERS

Angelalign Technology H1 Revenue USD 230.7 Million

THOMSON REUTERS

CLSA Adjusts 3SBIO Price Target Downward to HK$30.4, Keeps Outperform Rating

Ruili Aesthetics Reports Interim Profit Turnaround with Net Income of RMB 4.1 Million

Raily Aesthetic Medicine FY26 Interim Profit Turns to RMB 3.51 Million; Revenue Rises 35.7% to RMB 114.78 Million

Fosun Pharma Allocates 725,100 A-Share Options to Employees

Miricor Seeks Shareholder Approval for New Share Option Scheme with 10% Cap

Miricor Enterprises Announces Extraordinary General Meeting

HAOHAI BIOTEC Allocates HK$1.05 Million to Buy Back 63,800 Shares on August 28

Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":902.19464,"timestamp":1788163726135,"preClose":922.8416,"halted":0,"volume":133996901,"delay":0,"changeRate":-0.022373,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-20.646973,"latestTime":"08-31 16:00:00","open":922.6513,"high":922.6513,"low":893.9928,"amount":937121311,"amplitude":0.031055,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"pbRate":1.180847,"peRate":10.919282,"turnoverRate":0.006236,"increases":4,"decrements":7,"flats":2,"marketCap":148497744360,"floatMarketCap":111366366760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":922.6513,"amplitude":0.031055,"preClose":922.8416,"low":893.9928,"pbRate":"1.180847","latestPrice":902.19464,"volume":133996901,"delay":0,"open":922.6513,"prevYearClose":1094.978,"prevWeekClose":922.842,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":948.522,"twentyDayClose":935.405,"sixtyDayClose":858.687,"secType":"PLATE","market":"HK","turnoverRate":0.006236,"peRate":10.919282,"marketCap":148497744360,"floatMarketCap":111366366760,"timestamp":1788163726135,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":5,"down":6,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664291000","title":"Press Release: Angel's Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2664291000","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664291000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:07","pubTimestamp":1788203220,"startTime":"0","endTime":"0","summary":"SAN CLEMENTE, Calif.--(BUSINESS WIRE)--August 31, 2026--Angelalign Technology Inc. (\"Angel\" or the \"Company\") (6699.HK) (angelaligner.com), the second largest clear aligner supplier by revenue, announ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Angel's Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1583","BK1100","06699","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664022350","title":"Angelalign Technology Logs HY Revenue of USD 230.70 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664022350","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664022350?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:22","pubTimestamp":1788193372,"startTime":"0","endTime":"0","summary":"BRIEF-Angelalign Technology Logs HY Revenue Of USD 230.70 MillionAug 31 (Reuters)-Angelalign Technology Inc.6699.HK:HY REVENUE USD 230.70 MILLIONH1 NET PROFIT USD 25.50 MILLIONDECLARES INTERIM DIVIDEND HKD 0.47 PER SHARE AND SPECIAL DIVIDEND HKD 4.10 PER SHAREFurther company coverage:6699.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S08R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1593","BK1100","BK1583","06699"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007496","title":"Angelalign Technology (SEHK:6699) Is Getting Fresh Attention, What Is The Market Weighing?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007496","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007496?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:18","pubTimestamp":1788189500,"startTime":"0","endTime":"0","summary":"Angelalign Technology earnings update\nAngelalign Technology (SEHK:6699) reported half year 2026 earnings that caught investor attention, with sales of US$230.7 million and net income of US$27.25 million compared with the same period a year earlier.\nAngelalign Technology’s recent half year earnings sit against a strong rebound in the stock, with a 30 day share price return of 12.64% and a 90 day share price return of 25.61%. The 3 year total shareholder return of 82.77% contrasts sharply with...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-is-getting-fresh-attention-wh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-is-getting-fresh-attention-wh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06699","VOTE","JOYT","DECU","FEBU","PMDE","GXDW","BK1593","DCF","VGFPF","BK1583","BK1100","RGLO","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190704472","title":"Angelalign's Global Expansion Accelerates in First Half of 2026, with Steady Gains in Mainland China Market Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1190704472","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190704472?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:00","pubTimestamp":1788181218,"startTime":"0","endTime":"0","summary":"Angelalign Technology Inc (06699), the global clear aligner specialist, has unveiled robust results for the six-month period ending June 30, 2026. The company recorded a total of 316,609 case starts...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06699","BK1593","BK1100","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663053100","title":"China's Hongcheng Environmental Technology HY Revenue Rises on Higher Sulphuric Acid Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2663053100","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663053100?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:59","pubTimestamp":1788181171,"startTime":"0","endTime":"0","summary":"China's Hongcheng Environmental Technology HY revenue rises on higher sulphuric acid pricesOverviewChina environmental solutions provider's interim revenue rose 40% yr/yr for six months ended JuneGros","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0GW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06699","BK1593","BK1574","02265","BK1100","BK1140","BK1587","06609","BK1583","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175621165","title":"RAILY AESMED Cancels 47.28 Million Unexercised Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1175621165","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175621165?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:36","pubTimestamp":1788176175,"startTime":"0","endTime":"0","summary":"RAILY AESMED (02135) has announced that, following approval from its board of directors, which included the compensation committee, all 47.276 million unexercised share options previously granted to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1593","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070626","title":"Angelalign Technology Declares Interim Dividend of HKD 0.47 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070626","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070626?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:33","pubTimestamp":1788176015,"startTime":"0","endTime":"0","summary":"Angelalign Technology declares interim dividend of HKD 0.47 per shareAngelalign declared an interim dividend of HKD 0.47 per share for the six months ended June 30, 2026.Shares trade ex-dividend on Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9td5lw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","06699","BK1583","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070642","title":"Raily Aesthetic Medicine Cancels 47,276,437 Share Options Outstanding Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070642","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070642?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:33","pubTimestamp":1788176012,"startTime":"0","endTime":"0","summary":"Raily Aesthetic Medicine cancels 47,276,437 share options outstanding under incentive schemeRaily Aesthetic Medicine International Holdings cancelled 47,276,437 outstanding share options effective Aug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL63CqyW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1593","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077162","title":"China's Angelalign H1 Revenue Rises on Higher Clear Aligner Case Volume","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077162","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077162?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:13","pubTimestamp":1788174790,"startTime":"0","endTime":"0","summary":"China's Angelalign H1 revenue rises on higher clear aligner case volumeOverviewChina clear aligner maker's H1 2026 revenue rose 42.9% yr/yrAdjusted net profit for H1 2026 grew 79.5% yr/yrCompany attri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1587","BK1574","06609","01477","BK1593","06699","06622","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077303","title":"Angelalign FY26 H1 Net Profit Climbs 79.6% to USD 25.5 Million; Revenue Rises 42.9% to USD 230.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077303","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077303?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:05","pubTimestamp":1788174354,"startTime":"0","endTime":"0","summary":"Angelalign FY26 H1 net profit climbs 79.6% to USD 25.5 million; revenue rises 42.9% to USD 230.7 millionAngelalign posted IFRS net profit of USD 25.5 million, up 79.6%, on revenue of USD 230.7 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL6gjcPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK1593","BK1587","06699"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077865","title":"Angelalign Technology - Declares Interim Dividend HKD 0.47 Per Share and Special Dividend HKD 4.10 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077865?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:02","pubTimestamp":1788174123,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S08R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","06699","BK1593","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663720100","title":"Angelalign Technology H1 Revenue USD 230.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663720100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663720100?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:01","pubTimestamp":1788174090,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLXMMFWFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1593","06699","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111788244","title":"CLSA Adjusts 3SBIO Price Target Downward to HK$30.4, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1111788244","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111788244?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:00","pubTimestamp":1788148823,"startTime":"0","endTime":"0","summary":"According to a research report released by CLSA, the first-half performance of 3SBIO (01530) has benefited from milestone revenue related to its 707 program and robust growth in its CDMO business,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1583","BK1161","01530","BK1593","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163059918","title":"Ruili Aesthetics Reports Interim Profit Turnaround with Net Income of RMB 4.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1163059918","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163059918?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:24","pubTimestamp":1787927059,"startTime":"0","endTime":"0","summary":"RAILY AESMED (02135) has unveiled its interim results for the six months ended June 30, 2026, showcasing a positive financial shift. The company achieved a group revenue of RMB 115 million, marking a...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1593","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093761","title":"Raily Aesthetic Medicine FY26 Interim Profit Turns to RMB 3.51 Million; Revenue Rises 35.7% to RMB 114.78 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093761","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662093761?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:01","pubTimestamp":1787922075,"startTime":"0","endTime":"0","summary":"Raily Aesthetic Medicine FY26 interim profit turns to RMB 3.51 million; revenue rises 35.7% to RMB 114.78 millionRaily Aesthetic Medicine returned to profit, posting RMB 3.51 million profit, versus a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL8XSQb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1209","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184432934","title":"Fosun Pharma Allocates 725,100 A-Share Options to Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=1184432934","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184432934?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:00","pubTimestamp":1787914813,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has announced a new round of equity incentives, granting a total of 725,100 A-share options to 100 eligible recipients.According to the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","BK1191","BK1593","BK0060","83188","BK0012","82846","83130","03188","BK0183","BK0196","02196","BK0175","BK0188","BK1515","399300","BK0096","02827","600196","BK0028","BK0187","02846","159982","BK0239","07233","03130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662506479","title":"Miricor Seeks Shareholder Approval for New Share Option Scheme with 10% Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2662506479","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662506479?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:53","pubTimestamp":1787914436,"startTime":"0","endTime":"0","summary":"Miricor seeks shareholder approval for new share option scheme with 10% capMiricor scheduled a Sept. 18, 2026 EGM to vote on adopting a new share option scheme.The existing share option scheme, adopte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL7rK8TB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01827","BK1593","BK1215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662064799","title":"Miricor Enterprises Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662064799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662064799?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:53","pubTimestamp":1787914429,"startTime":"0","endTime":"0","summary":"Miricor Enterprises announces extraordinary general meetingMiricor Enterprises will hold an extraordinary general meeting in Hong Kong on Sept. 18, 2026.Shareholders will vote on terminating the exist","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL8JRl5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01827","BK1593","BK1215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137603738","title":"HAOHAI BIOTEC Allocates HK$1.05 Million to Buy Back 63,800 Shares on August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1137603738","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137603738?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:40","pubTimestamp":1787910020,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) has disclosed a share buyback transaction.On August 28, 2026, the company spent approximately HK$1.053 million to repurchase 63,800 of its own shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662056779","title":"Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662056779","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662056779?lang=en_us&edition=fundamental","pubTime":"2026-08-28 13:20","pubTimestamp":1787894451,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  GR1803 injection received conditional approval from China's National Medical Products Administration as a multiple myeloma treatment, according to a Friday disclosure on the Shanghai bourse.The drug, which has the generic name veritumab injection, is for adult patients with relapsed or refractory multiple myeloma who have previously received at least three lines of therapy, including a proteasome inhibitor and an anti-CD38 monoclonal antibody.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0096","BK1593","BK0187","BK0012","600196","BK0060","BK0188","02196","BK0175","BK1515","BK0028","BK0239","BK0183","BK0196","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}]}}